This invention is an effective combination pharmaceutical that consists of active ingredients of Traditional Chinese Medicine (TCM). The efficacy of this anti-cancer drug is comparable with, or even higher than that of 5-Fluorouracil (5FU), which is one of the chemotherapy drugs for treating cancer nowadays.
Drug resistance may be developed after prolonged usage of single-target anticancer drug. Combinational drug therapy is one of the most promising strategies in modern anticancer research. Using different combinations of anticancer drugs may exhibit synergistic effects and reduce the drug resistance. This multi-pronged effect could increase therapeutic efficacy.
Aspiring to be a leading, research-led, liberal arts University in Asia, Hong Kong Baptist University is committed to conducting world-leading investigations that extends the frontiers of knowledge, tackles global challenges and benefits the community at home and abroad.
Pursuing research excellence is one of the priorities of the University’s Institutional Strategic Plan 2018-2028. The University keeps enhancing its capacity and strength to produce world-class research with an aim to bring significant impact to the society.